Yesterday, a Director at Codexis (NASDAQ: CDXS), Patrick Yang, sold shares of CDXS for $2.17M.
Following Patrick Yang’s last CDXS Sell transaction on December 07, 2017, the stock climbed by 8.6%. This is Yang’s first Sell trade following 8 Buy transactions.
See today’s analyst top recommended stocks >>
Based on Codexis’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $13.54 million and GAAP net loss of $3.74 million. In comparison, last year the company earned revenue of $10.35 million and had a GAAP net loss of $6.28 million. Currently, Codexis has an average volume of 293.5K. The Company has a Price to Book ratio of 15.7377.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Codexis, Inc. engages in the discovery, development, and sale of proteins. It offers enzyme optimization services and developing biocatalyst products. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels.
